Source link : https://newshealth.biz/health-news/two-drugs-approved-for-npm1-mutated-leukemia/
(MedPage Today) — The FDA has approved two targeted menin inhibitors for the treatment of relapsed/refractory NPM1-mutated acute myeloid leukemia (AML). Ziftomenib (Komzifti) was approved on Thursday for adults with relapsed/refractory NPM1-mutated… Source link : https://www.medpagetoday.com/hematologyoncology/leukemia/118506 Author : Publish date : 2025-11-13 19:16:00 Copyright for syndicated content belongs to the linked Source.
The post Two Drugs Approved for NPM1-Mutated Leukemia first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-13 19:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8